000 01467 a2200433 4500
005 20250516001218.0
264 0 _c20101129
008 201011s 0 0 spa d
022 _a0025-7753
024 7 _a10.1016/j.medcli.2010.02.038
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSalinas, Carlos
245 0 0 _a[Three-month course of rifampicin and isoniazid for the treatment of latent tuberculous infection].
_h[electronic resource]
260 _bMedicina clinica
_cSep 2010
300 _a293-9 p.
_bdigital
500 _aPublication Type: Comparative Study; English Abstract; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntitubercular Agents
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsoniazid
_xadministration & dosage
650 0 4 _aLatent Tuberculosis
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMedication Adherence
650 0 4 _aProspective Studies
650 0 4 _aRifampin
_xadministration & dosage
650 0 4 _aTime Factors
650 0 4 _aYoung Adult
700 1 _aPascual Erquicia, Silvia
700 1 _aDiez, Rosa
700 1 _aAguirre, Urko
700 1 _aEgurrola, Mikel
700 1 _aAltube, Lander
700 1 _aCapelastegui, Alberto
773 0 _tMedicina clinica
_gvol. 135
_gno. 7
_gp. 293-9
856 4 0 _uhttps://doi.org/10.1016/j.medcli.2010.02.038
_zAvailable from publisher's website
999 _c20133884
_d20133884